Unlock stock picks and a broker-level newsfeed that powers Wall Street.
LSE - Delayed Quote GBp

Chill Brands Group PLC (CHLL.L)

Compare
2.1500
0.0000
(0.00%)
At close: May 31 at 5:08:22 PM GMT+1
Loading Chart for CHLL.L
  • Previous Close 2.1500
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 3.8900
  • Volume 28,710,000
  • Avg. Volume 0
  • Market Cap (intraday) 10.885M
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Mar 17, 2025 - Mar 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Chill Brands Group PLC engages in the research and development, production, and sale of cannabidiol consumer products and other lifestyle goods in the United States, the United Kingdom, and rest of Europe. It offers tobacco alternative products, including CBD-infused oral chew pouches and herbal smokes. The company also provides CBD-infused topical creams, beauty products, and ingestible tinctures, as well as nicotine-free vapour products. It serves its products under the Chill.com, Zoetic, and Chill Zero brands. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is based in London, the United Kingdom.

chillbrandsgroup.com

7

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CHLL.L

View More

Performance Overview: CHLL.L

Trailing total returns as of 3/14/2025, which may include dividends or other distributions. Benchmark is FTSE 100 .

YTD Return

CHLL.L
9,900.00%
FTSE 100
5.62%

1-Year Return

CHLL.L
4.88%
FTSE 100
11.48%

3-Year Return

CHLL.L
54.50%
FTSE 100
20.00%

5-Year Return

CHLL.L
68.84%
FTSE 100
60.87%

Compare To: CHLL.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHLL.L

View More

Valuation Measures

As of 3/14/2025
  • Market Cap

    10.89M

  • Enterprise Value

    13.79M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    42.17

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    94.03

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -44.64%

  • Return on Equity (ttm)

    -2,802.21%

  • Revenue (ttm)

    146.62k

  • Net Income Avi to Common (ttm)

    -3.64M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.95M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.79M

Research Analysis: CHLL.L

View More